Skip to content

Mannkind MNKD Additional Paid-In Capital

Additional Paid-In Capital at other companies

Eli Lilly logo
Eli LillyLLY
$6.92B+0.2%
LQD
Liquidia CorporationLQDA
$681.94M+5.7%
Tenet Healthcare logo
Tenet HealthcareTHC
$5.12B+6.2%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$2.22B+4.9%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$1.13B+65.3%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$1.4B+5.0%

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's additional paid-in capital?
Mannkind (MNKD) reported additional paid-in capital of $3.15B in Q1 2026.
How has Mannkind's additional paid-in capital changed year-over-year?
Mannkind's additional paid-in capital increased by 0.8% year-over-year, from $3.13B to $3.15B.
What is the long-term trend for Mannkind's additional paid-in capital?
Over 5 years (2020 to 2025), Mannkind's additional paid-in capital has grown at a 1.9% compound annual growth rate (CAGR), from $2.87B to $3.14B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.